Albertinen-Krankenhaus/Albertinen-Haus gGmbH

Hamburg 7 trials 3 recruiting

7 Registered trials

3 Currently recruiting

Organisation

Albertinen-Krankenhaus/Albertinen-Haus gGmbH

Location

Hamburg, Germany

Identifier

ORG-100020184

Address

Suentelstrasse 11a, Schnelsen, 22457, Germany

Departments

Clinic for Gynaecology and Obstetrics
gynaecologic oncology
Gynaecology Department
Gynäkologie
Gynäkologie und Geburtshilfe
Klinik für Gynäkologie und Geburtshilfe
Schwerpunkt Haematologie Onkologie Palliativmedizin

Clinical trials at this site (7)

Search interface

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) Recruiting

2025-520466-22-00 Advanced Platinum-resistant Epithelial Ovarian Cancer 5 2026-04-29
Evaluation of Niraparib alone compared to the combination of Niraparib and Bevacizumab in patients receiving chemotherapy for newly diagnose… Recruiting

2024-516066-11-00 Patients with newly diagnosed, histologically confirmed 5 2022-08-31
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
Combination of Abemaciclib and endocrine therapy in hormone receptor positive HER2 negative locally advanced or metastatic breast cancer wit… Ended

2024-511209-49-00 Patients with hormone receptor positive HER2 negative l 6 2022-04-26
The FIRST (First-line ovarian cancer treatment with Niraparib plus TSR-042) Study Ended

2024-510605-28-00 Stage 3 or 4 Non-mucinous Epithelial Ovarian Cancer 5 2018-11-27
This is a phase III randomised, double-blind, placebo-controlled, multicentre, global study to assess the effectiveness and safety of standa… Ended

2022-502747-35-00 Newly diagnosed advanced (FIGO stage III-IV) high grade 5 2019-02-18
HD21 Ended

2024-518022-33-00 Advanced Stage of Hodgkin Lymphoma 5 2016-07-15